Amylyx Pharmaceuticals, Inc. AMLX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s shares (diluted)?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported shares (diluted) of 110.6M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s shares (diluted) increased by 29.0% year-over-year, from 85.7M to 110.6M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s shares (diluted) has grown at a 93.2% compound annual growth rate (CAGR), from 26M to 362.7M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.